P-glycoprotein-like protein, a possible genetic marker for ivermectin resistance selection in Onchocerca volvulus

Molecular and Biochemical Parasitology

Volumn 158, Issue 2, 2008, Pages 101-111

  Bourguinat, Catherine ^a   Ardelli, Bernadette F ^b   Pion, Sébastien D S ^c   Kamgno, Joseph ^d   Gardon, Jacques ^e   Duke, Brian O L ^f   Boussinesq, Michel ^c   Prichard, Roger K ^a  

^a MCGILL UNIVERSITY   (Canada)

^b BRANDON UNIVERSITY   (Canada)

^c INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^d National Onchocerciasis Task Force Cameroon   (Cameroon)

^e INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^f River Blindness Foundation   (United Kingdom)

Author keywords

ABC transporters; DNA marker; Drug selection; Ivermectin; Onchocerca volvulus

Indexed keywords

GLYCOPROTEIN P; IVERMECTIN;

ADULT; AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC MARKER; GENETIC SELECTION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; ANTIPARASITIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; BASE SEQUENCE; CAMEROON; DRUG RESISTANCE; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENOTYPE; HELMINTH PROTEINS; HUMANS; IVERMECTIN; LINKAGE DISEQUILIBRIUM; MALE; MOLECULAR SEQUENCE DATA; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; P-GLYCOPROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA;

ANIMALIA; ONCHOCERCA VOLVULUS;

EID: 39149093966     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbiopara.2007.11.017     Document Type: Article

References (42)

1. Remme JHF, Feenstra J, Lever PR, et al. Tropical Diseases Targeted for Elimination: Chagas Disease, Lymphatic Filariasis, Onchocerciasis, and Leprosy: Disease Control Priorities in Developing Countries; 2006, p. 433-50.
2. Basanez M.G., Pion S.D., Churcher T.S., et al. River blindness: a success story under threat?. PLoS Med 3 (2006) e371
3. Ali M.M., Mukhtar M.M., Baraka O.Z., et al. Immunocompetence may be important in the effectiveness of Mectizan (ivermectin) in the treatment of human onchocerciasis. Acta Trop 84 (2002) 49-53
4. Awadzi K., Boakye D.A., Edwards G., et al. An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann Trop Med Parasitol 98 (2004) 231-249
5. Awadzi K., Attah S.K., Addy E.T., et al. Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann Trop Med Parasitol 98 (2004) 359-370
6. Osei-Atweneboana M.Y., Eng J.K., Boakye D.A., et al. Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two phase epidemiological study. Lancet 369 (2007) 2021-2029
7. Bourguinat C., Pion S.D., Kamgno J., et al. Genetic selection of low fertile Onchocerca volvulus by ivermectin treatment. PLoS Neg Trop Dis e72 (2007) 12-22
8. Eng J.K., Blackhall W.J., Osei-Atweneboana M.Y., et al. Ivermectin selection on beta-tubulin: evidence in Onchocerca volvulus and Haemonchus contortus. Mol Biochem Parasitol 150 (2006) 229-235
9. Eng J.K., and Prichard R.K. A comparison of genetic polymorphism in populations of Onchocerca volvulus from untreated- and ivermectin-treated patients. Mol Biochem Parasitol 142 (2005) 193-202
10. Ardelli B.F., and Prichard R.K. Identification of variant ABC-transporter genes among Onchocerca volvulus collected from ivermectin-treated and untreated patients in Ghana, West Africa. Ann Trop Med Parasitol 98 (2004) 371-384
11. Ardelli B.F., Guerriero S.B., and Prichard R.K. Genomic organization and effects of ivermectin selection on Onchocerca volvulus P-glycoprotein. Mol Biochem Parasitol 143 (2005) 58-66
12. Ardelli B.F., Guerriero S.B., and Prichard R.K. Characterization of a half-size ATP-binding cassette transporter gene which may be a useful marker for ivermectin selection in Onchocerca volvulus. Mol Biochem Parasitol 145 (2006) 94-100
13. Ardelli B.F., Guerriero S.B., and Prichard R.K. Ivermectin imposes selection pressure on P-glycoprotein from Onchocerca volvulus: linkage disequilibrium and genotype diversity. Parasitology 132 (2006) 375-386
14. Holland I.B., Cole S.P.C., Kuchler K., et al. ABC Proteins from Bacteria to Man (2003), Academic Press (Elsevier Science)
15. Pouliot J.F., L'Heureux F., Liu Z., et al. Reversal of P-glycoprotein-associated multidrug resistance by ivermectin. Biochem Pharmacol 53 (1997) 17-25
16. Lespine A., Martin S., Dupuy J., et al. Interaction of macrocyclic lactones with P-glycoprotein: structure-affinity relationship. Eur J Pharm Sci 30 (2007) 84-94
17. Lespine A., Dupuy J., Orlowski S., et al. Interaction of ivermectin with multidrug resistance proteins (MRP1, 2 and 3). Chem Biol Interact 159 (2006) 169-179
18. Ballent M., Lifschitz A., Virkel G., et al. Modulation of the P-glycoprotein-mediated intestinal secretion of ivermectin: in vitro and in vivo assessments. Drug Metab Dispos 34 (2006) 457-463
19. Le Jambre L.F., Dobson R.J., Lenane I.J., et al. Selection for anthelmintic resistance by macrocyclic lactones in Haemonchus contortus. Int J Parasitol 29 (1999) 1101-1111
20. Wolstenholme A.J., Fairweather I., Prichard R., et al. Drug resistance in veterinary helminths. Trends Parasitol 20 (2004) 469-476
21. Blackhall W.J., Liu H.Y., Xu M., et al. Selection at a P-glycoprotein gene in ivermectin- and moxidectin-selected strains of Haemonchus contortus. Mol Biochem Parasitol 95 (1998) 193-201
22. Sangster N.C., Bannan S.C., Weiss A.S., et al. Haemonchus contortus: sequence heterogeneity of internucleotide binding domains from P-glycoproteins. Exp Parasitol 91 (1999) 250-257
23. Xu M., Molento M., Blackhall W., et al. Ivermectin resistance in nematodes may be caused by alteration of P-glycoprotein homolog. Mol Biochem Parasitol 91 (1998) 327-335
24. Kerboeuf D., Blackhall W., Kaminsky R., et al. P-glycoprotein in helminths: function and perspectives for anthelmintic treatment and reversal of resistance. Int J Antimicrob Agents 22 (2003) 332-346
25. Hoerauf A., Adjei O., and Buttner D.W. Antibiotics for the treatment of onchocerciasis and other filarial infections. Curr Opin Invest Drugs 3 (2002) 533-537
26. Hoerauf A., Mand S., Volkmann L., et al. Doxycycline in the treatment of human onchocerciasis: kinetics of Wolbachia endobacteria reduction and of inhibition of embryogenesis in female Onchocerca worms. Microbes Infect 5 (2003) 261-273
27. Gardon J., Boussinesq M., Kamgno J., et al. Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomised controlled trial. Lancet 360 (2002) 203-210
28. Remme J., Ba O., Dadzie K.Y., et al. A force-of-infection model for onchocerciasis and its applications in the epidemiological evaluation of the Onchocerciasis Control Programme in the Volta River basin area. Bull World Health Organ 64 (1986) 667-681
29. Schulz-Key H. The collagenase technique: how to isolate and examine adult Onchocerca volvulus for the evaluation of drug effects. Trop Med Parasitol 39 Suppl. 4 (1988) 423-440
30. Klappenbach J.A., Saxman P.R., Cole J.R., et al. rrndb: the Ribosomal RNA Operon Copy Number Database. Nucleic Acids Res 29 (2001) 181-184
31. Huang Y.J., and Prichard R.K. Identification and stage-specific expression of two putative P-glycoprotein coding genes in Onchocerca volvulus. Mol Biochem Parasitol 102 (1999) 273-281
32. Williams R.L. A note on robust variance estimation for cluster-correlated data. Biometrics 56 (2000) 645-646
33. Prichard R. Genetic variability following selection of Haemonchus contortus with anthelmintics. Trends Parasitol 17 (2001) 445-453
34. Bourguinat C., Pion S.D., Kamgno J., et al. Genetic polymorphism of the beta-tubulin gene of Onchocerca volvulus in ivermectin naive patients from Cameroon, and its relationship with fertility of the worms. Parasitology 132 (2006) 255-262
35. Boussinesq M., Gardon J., Kamgno J., et al. Studies on the macrofilarial population of Onchocerca volvulus in hyper-endemic villages of the Central province of Cameroon. Ann Trop Med Parasitol 95 (2001) 379-388
36. Hartl D.L., and Clark A.G. Principles of Population Genetics. 2nd ed. (1989), Sinauer Associates, Inc.
37. Holmes A.R., Tsao S., Ong S.W., et al. Heterozygosity and functional allelic variation in the Candida albicans efflux pump genes CDR1 and CDR2. Mol Microbiol 62 (2006) 170-186
38. Safa A.R., Stern R.K., Choi K., et al. Molecular basis of preferential resistance to colchicine in multidrug-resistant human cells conferred by Gly-185-Val-185 substitution in P-glycoprotein. Proc Natl Acad Sci USA 87 (1990) 7225-7229
39. Ramachandra M., Ambudkar S.V., Gottesman M.M., et al. Functional characterization of a glycine 185-to-valine substitution in human P-glycoprotein by using a vaccinia-based transient expression system. Mol Biol Cell 7 (1996) 1485-1498
40. Rao U.S. Mutation of glycine 185 to valine alters the ATPase function of the human P-glycoprotein expressed in Sf9 cells. J Biol Chem 270 (1995) 6686-6690
41. Li B.W., Rush A.C., Tan J., et al. Quantitative analysis of gender-regulated transcripts in the filarial nematode Brugia malayi by real-time RT-PCR. Mol Biochem Parasitol 137 (2004) 329-337
42. Dent J.A., Smith M.M., Vassilatis D.K., et al. The genetics of ivermectin resistance in Caenorhabditis elegans. Proc Natl Acad Sci USA 97 (2000) 2674-2679